Frequency News and Research

RSS

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

QRxPharma Limited announced today initiation of its second pivotal Phase 3 registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo™IR, a patented 3:2 ratio fixed dose combination of morphine plus oxycodone.

11 Feb 2010

Elevator-related injuries are preventable

In the first large-scale epidemiological study of elevator-related injuries in older adults in the United States, researchers from the Indiana University School of Medicine and an Ohio State University colleague report in the January 2010 issue of The Journal of Trauma Injury, Infection, and Critical Care on the frequency, nature and opportunities for prevention of these injuries.

10 Feb 2010

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

St. Jude Medical, Inc. today announced European CE Mark approval of its USB cellular adaptor for the Merlin@home™ transmitter, a system that allows important patient data from an implantable cardiac device to be wirelessly downloaded and securely transmitted via telephone for review by a physician.

10 Feb 2010

Data provide key information about epigenetic profiles for gastric cancer

Gastric cancer, one of the most common types of cancer, is associated with high mortality rates. In the last decades, a decrease in the worldwide incidence has been observed with some changes in the therapeutic and diagnostic options.

10 Feb 2010

New filtration process to improve safety and quality of infant formula

Pall Corporation, a global leader in filtration, separation and purification, today introduced a new filtration process that significantly improves the safety and quality of infant formula. The Pall process is engineered to prevent microbial contamination through intensive filtration, while preserving nutritional quality by minimizing the need for repeated heat treatment during manufacturing.

From Pall Corporation 10 Feb 2010

FlowCardia commences enrollment in CROSSER CTO Recanalization Catheter study

FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), today announced Dr. John Paul Runyon from The Christ Hospital in Cincinnati, Ohio successfully enrolled the first patient into the CENTRAL (Crosser ENters The Right Arterial Lumen) study.

9 Feb 2010

Picis introduces LYNX C/Point revenue management solution for chemotherapy clinics

Picis today announced the immediate availability of an enhancement to its Picis LYNX C/Point® revenue management solution designed specifically for hospital-owned chemotherapy clinics.

9 Feb 2010

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute.

9 Feb 2010

Excessive TV viewing, lack of sleep and low frequency of family meals increases risk of childhood obesity

A new national study suggests that preschool-aged children are likely to have a lower risk for obesity if they regularly engage in one or more of three specific household routines: eating dinner as a family, getting adequate sleep and limiting their weekday television viewing time.

8 Feb 2010

10 helpful tips to safeguard Alzheimer's patients

An ID bracelet, like the one offered through the Alzheimer's Association's MedicAlert + Safe Return program, helps the police or a Good Samaritan get a missing person back home safely or medical attention.

5 Feb 2010

'Doctor Shopping': Data from California's prescription monitoring program

Research presented at the American Academy of Pain Medicine's 26th Annual Meeting provides early published data analyzing information gathered from California's prescription monitoring program, known as the Controlled Substances Utilization Review and Evaluation System (CURES). The analysis found a two-fold increase in the likelihood of individuals receiving opioids from multiple providers or "doctor shopping" when they were also being simultaneously prescribed a single additional class of a controlled substances, such as benzodiazepines or amphetamines.

5 Feb 2010

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical.

5 Feb 2010

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.

5 Feb 2010

Project Lifesaver International, Xanboo to offer medical facilities to help people with cognitive disorder

Project Lifesaver International, a non-profit organization specializing in training public safety agencies on search and rescue programs to help individuals with cognitive conditions that wander, announced today they will be teaming with Xanboo, a wireless equipment company that supplies a wide variety of intrusion and security products, including indoor and outdoor cameras, control of lighting, door/window censors, and other security products.

5 Feb 2010

BioMarin announces update on BMN 110 Phase I/II trial for Morquio A Syndrome

BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.

5 Feb 2010

Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five

Children who were exposed to acetaminophen prenatally were more likely to have asthma symptoms at age five in a study of 300 African-American and Dominican Republic children living in New York City.

5 Feb 2010

Lux Biosciences seeks US and European marketing approval for LUVENIQ

Lux Biosciences, Inc. today announced its submission of simultaneous regulatory filings to both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing approval for its investigational drug LUVENIQ™ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

5 Feb 2010

New technique may reduce recovery time in arrhythmia patients

A surgeon and an electrophysiologist in the Methodist DeBakey Heart & Vascular Center last week worked together to perform a novel, minimally-invasive procedure to treat a common but dangerous arrhythmia in a 61-year-old lawyer from east Texas who has suffered from the condition for months.

4 Feb 2010

Herbal remedies can aggravate asthma symptoms

Use of herbal remedies results in poorer quality of life and increased frequency of symptoms in asthma patients, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

3 Feb 2010

Researchers identify 1.1M base pairs of DNA in soybean genome

In 2009, soybeans represented an almost $30 billion industry in the U.S. alone, making soybeans the second-most profitable crop next to corn. Worldwide, soybeans have been used in human foods and livestock feed for centuries and have been a key component in industrial products, such as plastics and soy biodiesel, an environmentally friendly fuel.

2 Feb 2010

Frequency News and Research

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

Elevator-related injuries are preventable

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

Data provide key information about epigenetic profiles for gastric cancer

New filtration process to improve safety and quality of infant formula

FlowCardia commences enrollment in CROSSER CTO Recanalization Catheter study

Picis introduces LYNX C/Point revenue management solution for chemotherapy clinics

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Excessive TV viewing, lack of sleep and low frequency of family meals increases risk of childhood obesity

10 helpful tips to safeguard Alzheimer's patients

'Doctor Shopping': Data from California's prescription monitoring program

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

Project Lifesaver International, Xanboo to offer medical facilities to help people with cognitive disorder

BioMarin announces update on BMN 110 Phase I/II trial for Morquio A Syndrome

Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five

Lux Biosciences seeks US and European marketing approval for LUVENIQ

New technique may reduce recovery time in arrhythmia patients

Herbal remedies can aggravate asthma symptoms

Researchers identify 1.1M base pairs of DNA in soybean genome

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News